You should speak with a provider before considering BPC-157 if you: Have a chronic medical condition Take prescription medications Have immune system concerns Have a history of cancer Are pregnant or breastfeeding Are recovering from surgery Have ongoing pain or unexplained inflammation Are using other peptides, hormones, or performance compounds BPC-157 should not replace proper diagnosis, imaging, rehab, or medical treatment for injuries
This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 10 mg vial format
AOD 9604 is a 16-amino acid fragment derived from human growth hormone that targets fat cells directly
Progress should be assessed through body composition analysis, circumference measurements, and photos rather than scale weight alone, as muscle preservation can mask fat loss on the scale
Most people notice initial effects within the first few weeks, with more significant results appearing over several months